A study to evaluate how well single and multiple doses of O3R-5671-PRO are tolerated in healthy adult subjects

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-522571-28-00

Acronym

O3R-5671-CL-101

Enrollment

Registered

2025-08-13

Start date

2025-08-28

Completion date

Unknown

Last updated

2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory bowel diseases and psoriasis.

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Belgium

None listed

Source: EU CTIS · Data processed: Feb 4, 2026